EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Progression of Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Replacement: A Quantitative Coronary Angiography and Quantitative Flow Ratio Analysis

Jason Galo iD, Abdullah Al Qaraghuli, Cheng Zhang, Gal Peleg, Kalyan R Chitturi, Yonathan Hasin, Idit Avrahami, Shaan A Ahmed iD, Pablo M Rubio iD, Abhishek Chaturvedi iD, Beni Verma, Itsik Ben-Dor iD und 1 weitere

Catheterization and Cardiovascular Interventions · 2026

DOI: 10.1002/ccd.70704 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2026. Verfasst von Jason Galo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington DC, USA. Hauptthemen laut MEDLINE: Coronary Angiography, Coronary Artery Disease, Aortic Valve Stenosis, Coronary Circulation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The progression of coronary artery disease (CAD) following transcatheter aortic valve replacement (TAVR) is poorly understood. Changes in coronary hemodynamics after TAVR and their relationship with atherosclerosis remain an active area of investigation. Quantitative coronary angiography (QCA) and quantitative flow ratio (QFR) offer objective, reproducible assessments of coronary disease burden, hemodynamics, and progression.

Aims

To evaluate anatomic and hemodynamic progression of CAD in select patients undergoing TAVR using QCA and QFR, and to compare outcomes by valve type—self‐expanding valves (SEV) versus balloon‐expandable valves (BEV).

Methods

A total of 92 patients who underwent TAVR and had both pre‐ and post‐TAVR invasive coronary angiography (CA) were retrospectively analyzed. QCA and QFR analyses were performed on major coronary arteries. CAD progression was defined in 2 ways: (1) QCA diameter stenosis (DS) increase ≥ 10% or baseline < 50% and follow‑up ≥ 50%; (2) QFR decrease ≥ 0.05 or baseline QFR > 0.80 and follow‐up ≤ 0.80. Clinical and echocardiographic data, statin use, and antiplatelet therapy were assessed longitudinally.

Results

Over a median follow‐up of 756 days (IQR 254–1302), CAD progression in patients with clinically indicated post‐TAVR CA was observed in 96.6% of patients using QCA and in 85.6% of patients using QFR. Among vessel subsegments, CAD progression by QCA was greatest in the LAD proximal and mid segments (60.99% and 58.46%, respectively), and lowest in distal LCX and distal RCA (37.63%, 39.04%, respectively). CAD progression by QFR was significantly greater in SEV when compared to BEV (1‐year: 39.4% vs. 21.9%; 2‐year: 47.4% vs. 39.3%, log rank p = 0.038). There was no statistically significant difference in the QCA‐defined CAD progression between SEV and BEV, though a numerically higher progression was seen in SEV.

Conclusions

Most TAVR recipients undergoing clinically indicated repeat CA demonstrate CAD progression on serial angiography. By QFR, progression is influenced by valve type, while by QCA and QFR, trended with baseline disease severity. Further investigation into coronary progression following TAVR is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary AngiographyCoronary Artery DiseaseAortic Valve StenosisCoronary CirculationHemodynamicsAortic ValveCoronary VesselsTranscatheter Aortic Valve ReplacementHumansFemaleMaleDisease ProgressionRetrospective StudiesAged, 80 and overTreatment OutcomePredictive Value of TestsHeart Valve ProsthesisTime FactorsAgedProsthesis DesignSeverity of Illness IndexRisk FactorsBlood Flow VelocityCardiac Catheterization

Stichwörter der Autor:innen

coronary artery disease (CAD) progressioncoronary hemodynamicsquantitative coronary angiography (QCA)quantitative flow ratio (QFR)self‐expanding versus balloon‐expandable valvestranscatheter aortic valve replacement (TAVR)

Autor:innen und Institutionen

  • Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington DC, USA.
  • Department of Internal Medicine, MedStar Washington Hospital Center, Washington DC, USA.
  • Ariel University, Ariel, Israel.

ORCID-Profile: Jason Galo, Shaan A Ahmed, Pablo M Rubio, Abhishek Chaturvedi, Itsik Ben-Dor, Ron Waksman

Zitieren

APA

Galo, J., Al Qaraghuli, A., Zhang, C., Peleg, G., Chitturi, K. R., Hasin, Y., Avrahami, I., Ahmed, S. A., Rubio, P. M., Chaturvedi, A., Verma, B., Ben-Dor, I., & Waksman, R. (2026). Progression of Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Replacement: A Quantitative Coronary Angiography and Quantitative Flow Ratio Analysis. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70704

Vancouver

Galo J, Al Qaraghuli A, Zhang C, Peleg G, Chitturi KR, Hasin Y, et al. Progression of Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Replacement: A Quantitative Coronary Angiography and Quantitative Flow Ratio Analysis. Catheterization and Cardiovascular Interventions. 2026. doi:10.1002/ccd.70704

BibTeX
@article{Galo2026,
  author = {Galo, Jason and Al Qaraghuli, Abdullah and Zhang, Cheng and Peleg, Gal and Chitturi, Kalyan R and Hasin, Yonathan and Avrahami, Idit and Ahmed, Shaan A and Rubio, Pablo M and Chaturvedi, Abhishek and Verma, Beni and Ben-Dor, Itsik and Waksman, Ron},
  title = {Progression of Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Replacement: A Quantitative Coronary Angiography and Quantitative Flow Ratio Analysis},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2026},
  doi = {10.1002/ccd.70704}
}
Kostenlos starten →